Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
LOUISVILLE, Ky. -- Minimally invasive ablative therapy for early kidney cancer had an increased risk of local and metastatic recurrence, which is associated with increased mortality, Swedish ...
SurvivorNet on MSN
Enhertu significantly cuts recurrence rates for women with high-risk HER2-positive breast cancer — the practice-changing DESTINY-Breast05 trial
DESTINY-Breast05 is a large phase 3 trial in women with HER2-positive early-stage breast cancer who had chemotherapy and ...
PTNB before surgery in stage 1 NSCLC patients is linked to higher local-regional recurrence and mortality rates. The study included 2026 patients, with 38.6% undergoing PTNB, showing higher recurrence ...
In a recent study, obesity was linked to an increased risk of recurrence for patients with HR-positive, early-stage breast cancer. Obesity was associated with an increased recurrence risk for patients ...
Please provide your email address to receive an email when new articles are posted on . Surgical treatment yielded better 1-year outcomes for patients with vertebral osteomyelitis compared with ...
The risk for biochemical recurrence of prostate cancer after external beam radiation therapy varies by prostate cancer risk category. Investigators who studied men who underwent primary external beam ...
Breast cancer death rates have been declining since 1989, but the disease remains the second leading cause of cancer death in women. And incidence rates have increased slightly in recent years. For ...
One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...
Please provide your email address to receive an email when new articles are posted on . Five-year recurrence-free survival was 55.1% with nevus-associated acral melanoma (NAAM) vs. 42.3% with de novo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results